| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 5.61e-11 | 35 | 131 | 8 | GO:0015020 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 4.70e-10 | 28 | 131 | 7 | GO:0001972 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 3.89e-09 | 37 | 131 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 4.74e-09 | 38 | 131 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 5.04e-09 | 11 | 131 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.15e-08 | 14 | 131 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | retinoid binding | 2.62e-08 | 48 | 131 | 7 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 3.04e-08 | 49 | 131 | 7 | GO:0019840 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | GALNTL6 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 UGT2B10 FUT3 PLOD2 | 1.48e-07 | 211 | 131 | 11 | GO:0016758 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.11e-07 | 21 | 131 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | GALNTL6 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 UGT2B10 FUT3 ART5 PLOD2 | 4.45e-07 | 288 | 131 | 12 | GO:0016757 |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | GALNTL6 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 UGT2B10 | 7.67e-07 | 153 | 131 | 9 | GO:0008194 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 4.15e-06 | 37 | 131 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 4.75e-06 | 38 | 131 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 6.73e-06 | 107 | 131 | 7 | GO:0033293 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.24e-05 | 46 | 131 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 ERVK-7 UPF1 ERVK-10 ERVK-8 SMARCA2 HLTF SMARCA4 ERVK-11 | 5.90e-05 | 262 | 131 | 9 | GO:0140097 |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 6.54e-05 | 152 | 131 | 7 | GO:0016779 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | ERVK-6 HLA-A PSG5 PSG6 UGT1A10 UGT1A8 UGT1A7 UGT1A5 LRRK2 UGT1A9 UGT1A4 UGT1A3 RASIP1 TENM1 DGCR8 AADAT | 8.84e-05 | 815 | 131 | 16 | GO:0042803 |
| GeneOntologyMolecularFunction | endopeptidase activity | PCSK1 ERVK-6 USP34 NRDC ERVK-7 ERVK-10 TPP1 ERVK-8 ERVK-18 ERVK-19 ERVK-25 | 1.27e-04 | 430 | 131 | 11 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.72e-04 | 79 | 131 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.83e-04 | 239 | 131 | 8 | GO:0031406 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.10e-04 | 18 | 131 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | organic acid binding | 2.76e-04 | 254 | 131 | 8 | GO:0043177 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | PSG5 PSG6 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 TENM1 | 3.00e-04 | 398 | 131 | 10 | GO:0046982 |
| GeneOntologyMolecularFunction | ferric-chelate reductase (NADPH) activity | 4.22e-04 | 5 | 131 | 2 | GO:0052851 | |
| GeneOntologyMolecularFunction | ferric-chelate reductase activity | 4.22e-04 | 5 | 131 | 2 | GO:0000293 | |
| GeneOntologyMolecularFunction | cupric reductase (NADH) activity | 4.22e-04 | 5 | 131 | 2 | GO:0008823 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL3A1 ERVK-6 RPLP0P6 ERVK-7 ERVK-10 SSPOP HMCN2 HMCN1 ERVK-8 ERVK-18 ERVK-19 ERVK-25 PLEC PLS3 NUP160 | 7.53e-04 | 891 | 131 | 15 | GO:0005198 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 8.02e-04 | 28 | 131 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor | 8.78e-04 | 7 | 131 | 2 | GO:0016723 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 9.31e-04 | 66 | 131 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | fatty acid binding | 1.10e-03 | 69 | 131 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | peptidase activity | PCSK1 CPA6 ERVK-6 USP34 NRDC ERVK-7 ERVK-10 TPP1 ERVK-8 ERVK-18 ERVK-19 ERVK-25 | 1.26e-03 | 654 | 131 | 12 | GO:0008233 |
| GeneOntologyMolecularFunction | TAP complex binding | 1.49e-03 | 9 | 131 | 2 | GO:0062061 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.82e-03 | 37 | 131 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.82e-03 | 37 | 131 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.04e-03 | 136 | 131 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 2.04e-03 | 136 | 131 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ZCWPW2 ABCA13 UPF1 DNAH14 HSPA13 SMARCA2 SHOC1 HLTF SMARCA4 DNAH5 DNAH8 | 2.41e-03 | 614 | 131 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 3.69e-03 | 14 | 131 | 2 | GO:0005130 | |
| GeneOntologyMolecularFunction | helicase activity | 3.89e-03 | 158 | 131 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | glycolipid binding | 4.08e-03 | 49 | 131 | 3 | GO:0051861 | |
| GeneOntologyMolecularFunction | actin binding | 4.38e-03 | 479 | 131 | 9 | GO:0003779 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 3.57e-13 | 21 | 129 | 8 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 2.67e-12 | 26 | 129 | 8 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 2.67e-12 | 26 | 129 | 8 | GO:0006063 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 6.77e-09 | 12 | 129 | 5 | GO:0052697 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 7.27e-09 | 5 | 129 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 7.27e-09 | 5 | 129 | 4 | GO:0052696 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 1.09e-08 | 13 | 129 | 5 | GO:0009812 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.09e-08 | 13 | 129 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 2.17e-08 | 6 | 129 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 2.17e-08 | 6 | 129 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 2.17e-08 | 6 | 129 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 2.98e-07 | 10 | 129 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 2.98e-07 | 10 | 129 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 8.56e-07 | 52 | 129 | 6 | GO:0008210 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 2.97e-06 | 141 | 129 | 8 | GO:0006805 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 8.05e-06 | 21 | 129 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 1.22e-05 | 48 | 129 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 2.76e-05 | 94 | 129 | 6 | GO:0042440 | |
| GeneOntologyBiologicalProcess | gland development | PCSK1 PSG5 PSG6 UGT1A10 UGT1A8 UGT1A7 UGT1A9 SIX1 SMARCA4 LRP5 PLXNA1 SMAD2 IGSF3 | 4.86e-05 | 558 | 129 | 13 | GO:0048732 |
| GeneOntologyBiologicalProcess | steroid catabolic process | 5.86e-05 | 34 | 129 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 6.27e-05 | 67 | 129 | 5 | GO:0019748 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 7.93e-05 | 222 | 129 | 8 | GO:0071466 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 1.12e-04 | 40 | 129 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | UGT1A10 UGT1A8 UGT1A7 UGT1A9 LCAT H6PD UGT1A4 UGT1A3 UGT2B10 LRP5 | 1.29e-04 | 376 | 129 | 10 | GO:0008202 |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 1.74e-04 | 83 | 129 | 5 | GO:0006278 | |
| GeneOntologyBiologicalProcess | liver development | 2.84e-04 | 202 | 129 | 7 | GO:0001889 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 3.11e-04 | 205 | 129 | 7 | GO:0061008 | |
| GeneOntologyBiologicalProcess | iron ion import across cell outer membrane | 3.83e-04 | 5 | 129 | 2 | GO:0098706 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 4.44e-04 | 286 | 129 | 8 | GO:0042445 | |
| GeneOntologyBiologicalProcess | MHC class I protein complex assembly | 5.73e-04 | 6 | 129 | 2 | GO:0002397 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC class I protein complex | 5.73e-04 | 6 | 129 | 2 | GO:0002502 | |
| GeneOntologyBiologicalProcess | aortic smooth muscle cell differentiation | 5.73e-04 | 6 | 129 | 2 | GO:0035887 | |
| Domain | UDPGT | 3.79e-13 | 21 | 118 | 8 | PF00201 | |
| Domain | UDPGT | 3.79e-13 | 21 | 118 | 8 | PS00375 | |
| Domain | UDP_glucos_trans | 3.79e-13 | 21 | 118 | 8 | IPR002213 | |
| Domain | Ig-like_fold | HLA-A TAPBPL PSG5 PSG6 PSG7 IGDCC3 IGDCC4 HMCN2 HMCN1 FCGR1BP IL21R MYPN ROS1 IL2RG PLXNA1 IGSF3 IL27RA | 2.14e-06 | 706 | 118 | 17 | IPR013783 |
| Domain | IGc2 | 2.44e-06 | 235 | 118 | 10 | SM00408 | |
| Domain | Ig_sub2 | 2.44e-06 | 235 | 118 | 10 | IPR003598 | |
| Domain | - | HLA-A TAPBPL PSG5 PSG6 PSG7 IGDCC3 IGDCC4 HMCN1 FCGR1BP IL21R MYPN ROS1 IL2RG PLXNA1 IGSF3 IL27RA | 4.27e-06 | 663 | 118 | 16 | 2.60.40.10 |
| Domain | Gln-Leu-Gln_QLQ | 3.96e-05 | 2 | 118 | 2 | IPR014978 | |
| Domain | SnAC | 3.96e-05 | 2 | 118 | 2 | PF14619 | |
| Domain | QLQ | 3.96e-05 | 2 | 118 | 2 | SM00951 | |
| Domain | QLQ | 3.96e-05 | 2 | 118 | 2 | PS51666 | |
| Domain | SnAC | 3.96e-05 | 2 | 118 | 2 | SM01314 | |
| Domain | SnAC | 3.96e-05 | 2 | 118 | 2 | IPR029295 | |
| Domain | QLQ | 3.96e-05 | 2 | 118 | 2 | PF08880 | |
| Domain | IG_LIKE | HLA-A TAPBPL PSG5 PSG6 PSG7 IGDCC3 IGDCC4 HMCN2 HMCN1 FCGR1BP MYPN IGSF3 | 6.52e-05 | 491 | 118 | 12 | PS50835 |
| Domain | IG | TAPBPL PSG5 PSG6 PSG7 IGDCC3 IGDCC4 HMCN2 HMCN1 FCGR1BP MYPN IGSF3 | 7.38e-05 | 421 | 118 | 11 | SM00409 |
| Domain | Ig_sub | TAPBPL PSG5 PSG6 PSG7 IGDCC3 IGDCC4 HMCN2 HMCN1 FCGR1BP MYPN IGSF3 | 7.38e-05 | 421 | 118 | 11 | IPR003599 |
| Domain | Ig-like_dom | HLA-A TAPBPL PSG5 PSG6 PSG7 IGDCC3 IGDCC4 HMCN2 HMCN1 FCGR1BP MYPN IGSF3 | 8.20e-05 | 503 | 118 | 12 | IPR007110 |
| Domain | Dynein_heavy_chain_D4_dom | 8.51e-05 | 14 | 118 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 8.51e-05 | 14 | 118 | 3 | IPR024743 | |
| Domain | MT | 8.51e-05 | 14 | 118 | 3 | PF12777 | |
| Domain | AAA_8 | 8.51e-05 | 14 | 118 | 3 | PF12780 | |
| Domain | DHC_fam | 1.06e-04 | 15 | 118 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.06e-04 | 15 | 118 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.06e-04 | 15 | 118 | 3 | IPR004273 | |
| Domain | Propept_inh | 1.57e-04 | 17 | 118 | 3 | IPR009020 | |
| Domain | HSA | 2.36e-04 | 4 | 118 | 2 | SM00573 | |
| Domain | G2F | 2.36e-04 | 4 | 118 | 2 | PF07474 | |
| Domain | HSA | 2.36e-04 | 4 | 118 | 2 | PS51204 | |
| Domain | NIDOGEN_G2 | 2.36e-04 | 4 | 118 | 2 | PS50993 | |
| Domain | GFP | 2.36e-04 | 4 | 118 | 2 | IPR009017 | |
| Domain | HSA_dom | 2.36e-04 | 4 | 118 | 2 | IPR014012 | |
| Domain | HSA | 2.36e-04 | 4 | 118 | 2 | PF07529 | |
| Domain | G2_nidogen/fibulin_G2F | 2.36e-04 | 4 | 118 | 2 | IPR006605 | |
| Domain | ACTININ_2 | 3.97e-04 | 23 | 118 | 3 | PS00020 | |
| Domain | ACTININ_1 | 3.97e-04 | 23 | 118 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 3.97e-04 | 23 | 118 | 3 | IPR001589 | |
| Domain | BRK | 5.84e-04 | 6 | 118 | 2 | SM00592 | |
| Domain | BRK_domain | 5.84e-04 | 6 | 118 | 2 | IPR006576 | |
| Domain | BRK | 5.84e-04 | 6 | 118 | 2 | PF07533 | |
| Domain | Pept_M16_Zn_BS | 8.14e-04 | 7 | 118 | 2 | IPR001431 | |
| Domain | Pept_M16_dom | 8.14e-04 | 7 | 118 | 2 | IPR011237 | |
| Domain | Metalloenz_LuxS/M16 | 8.14e-04 | 7 | 118 | 2 | IPR011249 | |
| Domain | Peptidase_M16 | 8.14e-04 | 7 | 118 | 2 | PF00675 | |
| Domain | Peptidase_M16_C | 8.14e-04 | 7 | 118 | 2 | IPR007863 | |
| Domain | Peptidase_M16_C | 8.14e-04 | 7 | 118 | 2 | PF05193 | |
| Domain | Pept_M16_N | 8.14e-04 | 7 | 118 | 2 | IPR011765 | |
| Domain | - | 8.14e-04 | 7 | 118 | 2 | 3.30.830.10 | |
| Domain | INSULINASE | 8.14e-04 | 7 | 118 | 2 | PS00143 | |
| Domain | SNF2_N | 1.07e-03 | 32 | 118 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.07e-03 | 32 | 118 | 3 | PF00176 | |
| Domain | DHC_N1 | 1.08e-03 | 8 | 118 | 2 | PF08385 | |
| Domain | HEMATOPO_REC_S_F1 | 1.08e-03 | 8 | 118 | 2 | PS01355 | |
| Domain | Dynein_heavy_dom-1 | 1.08e-03 | 8 | 118 | 2 | IPR013594 | |
| Domain | FN3 | 1.15e-03 | 185 | 118 | 6 | SM00060 | |
| Domain | Ig_2 | 1.18e-03 | 73 | 118 | 4 | PF13895 | |
| Domain | ig | 1.32e-03 | 190 | 118 | 6 | PF00047 | |
| Domain | Immunoglobulin | 1.32e-03 | 190 | 118 | 6 | IPR013151 | |
| Domain | Hempt_rcpt_S_F1_CS | 1.38e-03 | 9 | 118 | 2 | IPR003531 | |
| Domain | FN3 | 1.66e-03 | 199 | 118 | 6 | PS50853 | |
| Domain | Ig_V-set | 1.66e-03 | 199 | 118 | 6 | IPR013106 | |
| Domain | - | 1.90e-03 | 39 | 118 | 3 | 2.120.10.30 | |
| Domain | - | 2.10e-03 | 11 | 118 | 2 | 3.40.50.200 | |
| Domain | Peptidase_S8/S53_dom | 2.10e-03 | 11 | 118 | 2 | IPR000209 | |
| Domain | Peptidase_S8 | 2.10e-03 | 11 | 118 | 2 | PF00082 | |
| Domain | FN3_dom | 2.13e-03 | 209 | 118 | 6 | IPR003961 | |
| Domain | Ferric_reduct | 2.51e-03 | 12 | 118 | 2 | PF01794 | |
| Domain | Fe3_Rdtase_TM_dom | 2.51e-03 | 12 | 118 | 2 | IPR013130 | |
| Domain | DUF4599 | 2.51e-03 | 12 | 118 | 2 | PF15371 | |
| Domain | DUF4599 | 2.51e-03 | 12 | 118 | 2 | IPR027970 | |
| Domain | 6-blade_b-propeller_TolB-like | 3.06e-03 | 46 | 118 | 3 | IPR011042 | |
| Domain | Dynein_heavy_dom-2 | 3.43e-03 | 14 | 118 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.43e-03 | 14 | 118 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.43e-03 | 14 | 118 | 2 | IPR011704 | |
| Domain | AAA_5 | 3.43e-03 | 14 | 118 | 2 | PF07728 | |
| Domain | fn3 | 3.68e-03 | 162 | 118 | 5 | PF00041 | |
| Domain | LY | 3.94e-03 | 15 | 118 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.94e-03 | 15 | 118 | 2 | IPR000033 | |
| Domain | V-set | 6.28e-03 | 184 | 118 | 5 | PF07686 | |
| Pathway | REACTOME_GLUCURONIDATION | 5.13e-13 | 24 | 80 | 8 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 7.52e-13 | 25 | 80 | 8 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 7.52e-13 | 25 | 80 | 8 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 7.52e-13 | 25 | 80 | 8 | M605 | |
| Pathway | WP_GLUCURONIDATION | 1.08e-12 | 26 | 80 | 8 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 2.13e-12 | 28 | 80 | 8 | M19580 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 6.17e-11 | 41 | 80 | 8 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.37e-10 | 45 | 80 | 8 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 3.93e-10 | 51 | 80 | 8 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 4.62e-10 | 52 | 80 | 8 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 7.38e-10 | 55 | 80 | 8 | M14933 | |
| Pathway | WP_ESTROGEN_METABOLISM | 1.92e-09 | 22 | 80 | 6 | MM15888 | |
| Pathway | KEGG_RETINOL_METABOLISM | 2.58e-09 | 64 | 80 | 8 | M9488 | |
| Pathway | REACTOME_ASPIRIN_ADME | 4.69e-09 | 44 | 80 | 7 | M45014 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 5.35e-09 | 70 | 80 | 8 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 6.72e-09 | 72 | 80 | 8 | M9257 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.56e-07 | 107 | 80 | 8 | MM14595 | |
| Pathway | REACTOME_DRUG_ADME | 1.80e-07 | 109 | 80 | 8 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.80e-07 | 109 | 80 | 8 | M18788 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 NDST3 CYP2U1 | 1.98e-07 | 153 | 80 | 9 | MM15844 |
| Pathway | REACTOME_DRUG_ADME | 3.55e-07 | 119 | 80 | 8 | MM15692 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 CES3 UGT2B10 CYP2U1 | 4.25e-07 | 219 | 80 | 10 | MM14838 |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 CES3 UGT2B10 CYP2U1 | 4.43e-07 | 220 | 80 | 10 | M10320 |
| Pathway | REACTOME_PARACETAMOL_ADME | 2.57e-06 | 39 | 80 | 5 | MM15695 | |
| Pathway | REACTOME_PREDNISONE_ADME | 7.84e-06 | 23 | 80 | 4 | MM16639 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 9.04e-06 | 183 | 80 | 8 | M39588 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 6.12e-05 | 14 | 80 | 3 | M39328 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 7.62e-05 | 15 | 80 | 3 | MM15697 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 1.20e-04 | 45 | 80 | 4 | M39615 | |
| Pathway | REACTOME_HEME_DEGRADATION | 1.87e-04 | 20 | 80 | 3 | MM14721 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 2.17e-04 | 21 | 80 | 3 | M39631 | |
| Pathway | WP_ARYLAMINE_METABOLISM | 4.70e-04 | 6 | 80 | 2 | M39437 | |
| Pathway | WP_NICOTINE_METABOLISM_IN_LIVER_CELLS | 4.70e-04 | 6 | 80 | 2 | M39600 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 4.70e-04 | 6 | 80 | 2 | MM15621 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 7.75e-04 | 32 | 80 | 3 | MM14719 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.39e-03 | 10 | 80 | 2 | M27898 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 1.39e-03 | 145 | 80 | 5 | M45512 | |
| Pathway | WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING | 1.84e-03 | 43 | 80 | 3 | M45516 | |
| Pathway | REACTOME_LYSINE_CATABOLISM | 2.02e-03 | 12 | 80 | 2 | M27680 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 2.02e-03 | 12 | 80 | 2 | M39611 | |
| Pathway | REACTOME_LYSINE_CATABOLISM | 2.02e-03 | 12 | 80 | 2 | MM15400 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 1.02e-16 | 14 | 132 | 8 | 14672974 | |
| Pubmed | 3.45e-16 | 9 | 132 | 7 | 22511988 | ||
| Pubmed | 1.15e-15 | 10 | 132 | 7 | 23642732 | ||
| Pubmed | 1.15e-15 | 10 | 132 | 7 | 11465080 | ||
| Pubmed | 1.15e-15 | 10 | 132 | 7 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 1.15e-15 | 10 | 132 | 7 | 22558097 | |
| Pubmed | 7.53e-15 | 12 | 132 | 7 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 7.53e-15 | 12 | 132 | 7 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 1.63e-14 | 13 | 132 | 7 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 1.63e-14 | 13 | 132 | 7 | 25246029 | |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 1.86e-14 | 7 | 132 | 6 | 8467709 | |
| Pubmed | 1.86e-14 | 7 | 132 | 6 | 8464825 | ||
| Pubmed | 3.24e-14 | 14 | 132 | 7 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 3.24e-14 | 14 | 132 | 7 | 10836148 | |
| Pubmed | 3.24e-14 | 14 | 132 | 7 | 9295054 | ||
| Pubmed | 7.42e-14 | 8 | 132 | 6 | 20610558 | ||
| Pubmed | 7.42e-14 | 8 | 132 | 6 | 17179145 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 1.07e-13 | 16 | 132 | 7 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 1.82e-13 | 17 | 132 | 7 | 20639394 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 4.69e-13 | 19 | 132 | 7 | 23281178 | |
| Pubmed | 7.30e-13 | 5 | 132 | 5 | 15057901 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 2.42e-12 | 12 | 132 | 6 | 20308471 | |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 3.17e-12 | 24 | 132 | 7 | 24625756 | |
| Pubmed | 4.05e-11 | 8 | 132 | 5 | 18052087 | ||
| Pubmed | 9.08e-11 | 9 | 132 | 5 | 1339448 | ||
| Pubmed | 1.66e-10 | 66 | 132 | 8 | 19898482 | ||
| Pubmed | 1.98e-10 | 4 | 132 | 4 | 9271343 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 9.88e-10 | 5 | 132 | 4 | 12629516 | |
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 2.18e-09 | 57 | 132 | 7 | 21886157 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-11 | 2.94e-09 | 94 | 132 | 8 | 21542922 |
| Pubmed | 2.96e-09 | 6 | 132 | 4 | 32527940 | ||
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 2.96e-09 | 6 | 132 | 4 | 19204906 | |
| Pubmed | 2.96e-09 | 6 | 132 | 4 | 20297805 | ||
| Pubmed | 6.01e-09 | 18 | 132 | 5 | 20056724 | ||
| Pubmed | 6.88e-09 | 7 | 132 | 4 | 27514509 | ||
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 1.37e-08 | 8 | 132 | 4 | 12695355 | |
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 12847094 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 29519853 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 10516026 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 23611809 | ||
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A3 SMARCA2 ALDH4A1 UQCRC1 | 8.99e-08 | 203 | 132 | 9 | 16916647 |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.25e-07 | 211 | 132 | 9 | 24097068 | |
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 2.13e-07 | 4 | 132 | 3 | 18223459 | |
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 9535849 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 2.13e-07 | 4 | 132 | 3 | 10469592 | |
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 7983737 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 17558305 | ||
| Pubmed | 5.31e-07 | 5 | 132 | 3 | 20565459 | ||
| Pubmed | 5.82e-07 | 18 | 132 | 4 | 18664271 | ||
| Pubmed | Characterization of cDNA encoding novel pregnancy-specific glycoprotein variants. | 1.85e-06 | 7 | 132 | 3 | 7794280 | |
| Pubmed | 2.95e-06 | 8 | 132 | 3 | 22579593 | ||
| Pubmed | 2.95e-06 | 8 | 132 | 3 | 1690992 | ||
| Pubmed | 2.95e-06 | 8 | 132 | 3 | 10748067 | ||
| Pubmed | 4.37e-06 | 29 | 132 | 4 | 36800290 | ||
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 4.41e-06 | 9 | 132 | 3 | 20732626 | |
| Pubmed | 8.62e-06 | 190 | 132 | 7 | 24816252 | ||
| Pubmed | 8.62e-06 | 11 | 132 | 3 | 18695635 | ||
| Pubmed | 1.15e-05 | 12 | 132 | 3 | 18161889 | ||
| Pubmed | 1.15e-05 | 12 | 132 | 3 | 14557543 | ||
| Pubmed | Genomic structure and chromosomal localization of the mouse gene Punc. | 1.43e-05 | 2 | 132 | 2 | 9922388 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 8670841 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23163725 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 8068691 | ||
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 1.43e-05 | 2 | 132 | 2 | 23076393 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 15576411 | ||
| Pubmed | Tapasin-related protein TAPBPR is an additional component of the MHC class I presentation pathway. | 1.43e-05 | 2 | 132 | 2 | 23401559 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 15240517 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 26564006 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 1.43e-05 | 2 | 132 | 2 | 33027072 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23872584 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 24641623 | ||
| Pubmed | Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. | 1.43e-05 | 2 | 132 | 2 | 23088494 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 20333683 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 34812766 | ||
| Pubmed | Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy. | 1.43e-05 | 2 | 132 | 2 | 30478150 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 11677206 | ||
| Pubmed | Interaction of TAPBPR, a tapasin homolog, with MHC-I molecules promotes peptide editing. | 1.43e-05 | 2 | 132 | 2 | 26869717 | |
| Pubmed | The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. | 1.43e-05 | 2 | 132 | 2 | 25808524 | |
| Pubmed | Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. | 1.43e-05 | 2 | 132 | 2 | 19144648 | |
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 1.43e-05 | 2 | 132 | 2 | 10497143 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12944498 | ||
| Pubmed | High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer. | 1.43e-05 | 2 | 132 | 2 | 29391527 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 37634210 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17529886 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 8208605 | ||
| Pubmed | ROS1-Rearranged Non-Small-Cell Lung Cancer, Factor V Leiden, and Recurrent Venous Thromboses. | 1.43e-05 | 2 | 132 | 2 | 29945753 | |
| Pubmed | A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. | 1.43e-05 | 2 | 132 | 2 | 11163203 | |
| Pubmed | Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. | 1.43e-05 | 2 | 132 | 2 | 12620226 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 27039070 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 29848589 | ||
| Pubmed | Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein. | 1.43e-05 | 2 | 132 | 2 | 9603422 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25547628 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23276717 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 27097303 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 28038711 | ||
| Pubmed | Increased UGT1A3 and UGT1A7 expression is associated with pancreatic cancer. | 1.43e-05 | 2 | 132 | 2 | 25743847 | |
| Pubmed | Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury. | 1.43e-05 | 2 | 132 | 2 | 23963727 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12493776 | ||
| Pubmed | Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4. | 1.43e-05 | 2 | 132 | 2 | 31375262 | |
| Pubmed | Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues. | 1.43e-05 | 2 | 132 | 2 | 32035013 | |
| Interaction | UGT1A7 interactions | 1.48e-06 | 57 | 126 | 6 | int:UGT1A7 | |
| Cytoband | 2q37 | 3.25e-12 | 31 | 131 | 7 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 4.25e-06 | 226 | 131 | 7 | chr2q37 | |
| Cytoband | 11q22.1 | 7.19e-04 | 14 | 131 | 2 | 11q22.1 | |
| GeneFamily | UDP glucuronosyltransferases | 1.63e-12 | 32 | 85 | 8 | 363 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 1.61e-05 | 11 | 85 | 3 | 1315 | |
| GeneFamily | Dyneins, axonemal | 6.50e-05 | 17 | 85 | 3 | 536 | |
| GeneFamily | Proteases, serine|STEAP family | 2.16e-04 | 5 | 85 | 2 | 1324 | |
| GeneFamily | Fibulins | 6.00e-04 | 8 | 85 | 2 | 556 | |
| GeneFamily | Fibronectin type III domain containing | 9.46e-04 | 160 | 85 | 5 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 9.73e-04 | 161 | 85 | 5 | 593 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 1.01e-03 | 42 | 85 | 3 | 602 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR | 8.47e-06 | 154 | 123 | 7 | MM1313 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-07 | 184 | 124 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-07 | 184 | 124 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-07 | 184 | 124 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 9.91e-07 | 188 | 124 | 7 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.24e-06 | 162 | 124 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 191 | 124 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Severe-Treg|World / Disease group and Cell class | 1.59e-05 | 191 | 124 | 6 | 0a80b8c317e8da4d4722cfd13cdabc32b58021eb | |
| ToppCell | BL-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.74e-05 | 194 | 124 | 6 | 2932f704656ca368565ec12f3452af3b18e8df12 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-05 | 194 | 124 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.79e-05 | 195 | 124 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.79e-05 | 195 | 124 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-05 | 197 | 124 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 124 | 6 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Differentiating_Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.07e-05 | 200 | 124 | 6 | a552a99f5e4fa00dfb7775e5a3e1f62f1530d104 | |
| Drug | cotinine-N-glucuronide | 6.78e-16 | 13 | 122 | 8 | CID000000411 | |
| Drug | AC1MRQNQ | 3.80e-15 | 9 | 122 | 7 | CID003522271 | |
| Drug | DHPASiU | 3.80e-15 | 9 | 122 | 7 | CID000197602 | |
| Drug | 3-iodophenol | 3.80e-15 | 9 | 122 | 7 | CID000012272 | |
| Drug | AC1L4J7U | 3.80e-15 | 9 | 122 | 7 | CID000186631 | |
| Drug | Chebi:32663 | 3.80e-15 | 9 | 122 | 7 | CID005460873 | |
| Drug | ApApG | 2.25e-14 | 18 | 122 | 8 | CID003081975 | |
| Drug | C1 11-32 | 2.25e-14 | 18 | 122 | 8 | CID000443077 | |
| Drug | C11131 | 2.25e-14 | 18 | 122 | 8 | CID000443076 | |
| Drug | 4-nitrophenyl)imidazole | 3.45e-14 | 11 | 122 | 7 | CID000123155 | |
| Drug | AC1O5XMV | 3.45e-14 | 11 | 122 | 7 | CID006442661 | |
| Drug | NNAL | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 UGT2B10 PLEC | 6.82e-14 | 32 | 122 | 9 | CID000104856 |
| Drug | N-OH-DABZ | 8.25e-14 | 12 | 122 | 7 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 8.25e-14 | 12 | 122 | 7 | CID000088735 | |
| Drug | 2,4,6-TCB | 8.25e-14 | 12 | 122 | 7 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 8.25e-14 | 12 | 122 | 7 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 8.25e-14 | 12 | 122 | 7 | CID000276709 | |
| Drug | estriol-16-glucuronide | 1.03e-13 | 21 | 122 | 8 | CID000122281 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 UGT2B10 PLEC | 1.69e-13 | 35 | 122 | 9 | CID010436171 |
| Drug | tritanol | 1.78e-13 | 13 | 122 | 7 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.78e-13 | 13 | 122 | 7 | CID003081279 | |
| Drug | estradiol-3-glucuronide | 2.47e-13 | 23 | 122 | 8 | CID000066651 | |
| Drug | propranolol glucuronide | 3.54e-13 | 14 | 122 | 7 | CID000119515 | |
| Drug | PCB-61 | 3.54e-13 | 14 | 122 | 7 | CID000036401 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 6.62e-13 | 15 | 122 | 7 | CID000040469 | |
| Drug | afloqualone | 6.62e-13 | 15 | 122 | 7 | CID000002040 | |
| Drug | naphthyl sulphate | 6.62e-13 | 15 | 122 | 7 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 6.62e-13 | 15 | 122 | 7 | CID000010752 | |
| Drug | sulforaphane nitrile | 6.62e-13 | 15 | 122 | 7 | CID000543743 | |
| Drug | diflunisal | 1.10e-12 | 27 | 122 | 8 | CID000003059 | |
| Drug | quercetin-3,4'-diglucoside | 1.17e-12 | 16 | 122 | 7 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 1.17e-12 | 16 | 122 | 7 | CID000040003 | |
| Drug | bilirubin-phosphate | 1.17e-12 | 16 | 122 | 7 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 1.98e-12 | 17 | 122 | 7 | CID000003573 | |
| Drug | 6-hydroxychrysene | 1.98e-12 | 17 | 122 | 7 | CID000037766 | |
| Drug | 7-hydroxycoumarin glucuronide | 2.10e-12 | 29 | 122 | 8 | CID000125641 | |
| Drug | SureCN12722713 | 3.23e-12 | 18 | 122 | 7 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 3.23e-12 | 18 | 122 | 7 | CID000152226 | |
| Drug | Br 2 | 3.23e-12 | 18 | 122 | 7 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 3.23e-12 | 18 | 122 | 7 | CID000036614 | |
| Drug | 9-OH-risperidone | 5.09e-12 | 19 | 122 | 7 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 5.09e-12 | 19 | 122 | 7 | CID000091433 | |
| Drug | almokalant | 5.09e-12 | 19 | 122 | 7 | CID003033962 | |
| Drug | norbuprenorphine | 6.69e-12 | 33 | 122 | 8 | CID000114976 | |
| Drug | AC1Q6OQG | 6.69e-12 | 33 | 122 | 8 | CID000009686 | |
| Drug | BP-3,6-quinol | 6.69e-12 | 33 | 122 | 8 | CID000119292 | |
| Drug | tectochrysin | 7.80e-12 | 20 | 122 | 7 | CID005281954 | |
| Drug | AC1L1OBF | 7.80e-12 | 20 | 122 | 7 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 7.80e-12 | 20 | 122 | 7 | CID000116545 | |
| Drug | bropirimine | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 SMARCA2 LRP5 | 8.18e-12 | 52 | 122 | 9 | CID000065457 |
| Drug | 16-epiestriol | PSG5 PSG6 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 UGT2B10 | 1.09e-11 | 77 | 122 | 10 | CID000003269 |
| Drug | AC1NOWCJ | 1.12e-11 | 35 | 122 | 8 | CID005120112 | |
| Drug | estrone-3-glucuronide | 1.12e-11 | 35 | 122 | 8 | CID000115255 | |
| Drug | dulcin | 1.16e-11 | 21 | 122 | 7 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 1.16e-11 | 21 | 122 | 7 | CID000069186 | |
| Drug | anisole | 1.44e-11 | 36 | 122 | 8 | CID000007519 | |
| Drug | bevirimat | 1.44e-11 | 36 | 122 | 8 | CID000457928 | |
| Drug | amonafide | 1.70e-11 | 22 | 122 | 7 | CID000050515 | |
| Drug | N-methylpiperazine | 1.70e-11 | 22 | 122 | 7 | CID000053167 | |
| Drug | l-borneol | 1.83e-11 | 37 | 122 | 8 | CID000010049 | |
| Drug | amidoxime | 2.43e-11 | 23 | 122 | 7 | CID000465967 | |
| Drug | phenanthridine | 2.43e-11 | 23 | 122 | 7 | CID000009189 | |
| Drug | lithocholic acid | HLA-A UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 SLC34A1 UGT2B10 PLEC | 3.23e-11 | 116 | 122 | 11 | CID000009903 |
| Drug | AS-3201 | 3.42e-11 | 24 | 122 | 7 | CID000153948 | |
| Drug | harmol | 3.59e-11 | 40 | 122 | 8 | CID000068094 | |
| Drug | buprenorphine hydrochloride solution | 4.44e-11 | 41 | 122 | 8 | CID000002476 | |
| Drug | testosterone glucuronide | 4.44e-11 | 41 | 122 | 8 | CID000108192 | |
| Drug | 5-MOP | 4.73e-11 | 25 | 122 | 7 | CID000002355 | |
| Drug | AzMC | 4.73e-11 | 25 | 122 | 7 | CID000064986 | |
| Drug | N-acetylbenzidine | 4.73e-11 | 25 | 122 | 7 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 4.73e-11 | 25 | 122 | 7 | CID000006796 | |
| Drug | N-phenylmaleimide | 4.73e-11 | 25 | 122 | 7 | CID000013662 | |
| Drug | 3-OHBaP | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 H6PD UGT1A4 UGT1A3 UGT2B10 | 5.01e-11 | 63 | 122 | 9 | CID000025890 |
| Drug | PTBP | 5.46e-11 | 42 | 122 | 8 | CID000007393 | |
| Drug | Woodward's reagent K | 6.68e-11 | 43 | 122 | 8 | CID000077804 | |
| Drug | androsterone glucuronide | 6.68e-11 | 43 | 122 | 8 | CID000114833 | |
| Drug | 7,8-benzoquinoline | 6.68e-11 | 43 | 122 | 8 | CID000009191 | |
| Drug | MS-222 | 8.13e-11 | 44 | 122 | 8 | CID000011400 | |
| Drug | DiMeIQx | 8.66e-11 | 27 | 122 | 7 | CID000104739 | |
| Drug | Meldola | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 SMARCA2 UGT2B10 | 1.02e-10 | 68 | 122 | 9 | CID000081507 |
| Drug | CARMINE | 1.15e-10 | 28 | 122 | 7 | CID000014749 | |
| Drug | erucin | 1.15e-10 | 28 | 122 | 7 | CID000078160 | |
| Drug | N-hydroxy-4-aminobiphenyl | 1.15e-10 | 28 | 122 | 7 | CID000081261 | |
| Drug | H-Ni | 1.15e-10 | 28 | 122 | 7 | CID000445665 | |
| Drug | 1-naphthol | PCSK1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 UGT2B10 PLEC | 1.26e-10 | 98 | 122 | 10 | CID000007005 |
| Drug | 1h1q | 1.33e-10 | 70 | 122 | 9 | CID000001540 | |
| Drug | AC1L1JAL | 1.51e-10 | 29 | 122 | 7 | CID000004954 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 1.51e-10 | 29 | 122 | 7 | CID005375667 | |
| Drug | trans-3'-hydroxycotinine | 1.51e-10 | 29 | 122 | 7 | CID000000414 | |
| Drug | iberin | 1.51e-10 | 29 | 122 | 7 | CID000010455 | |
| Drug | 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine | 1.51e-10 | 29 | 122 | 7 | ctd:C060533 | |
| Drug | salicylamide | 1.70e-10 | 48 | 122 | 8 | CID000005147 | |
| Drug | tolcapone | 1.96e-10 | 30 | 122 | 7 | CID004659569 | |
| Drug | paricalcitol | 1.96e-10 | 30 | 122 | 7 | CID005281104 | |
| Drug | AC1L9E0Q | 1.96e-10 | 30 | 122 | 7 | CID000443095 | |
| Drug | dihydroartemisinin | 1.96e-10 | 30 | 122 | 7 | CID000107770 | |
| Drug | AC1L1G0K | 2.02e-10 | 49 | 122 | 8 | CID000003473 | |
| Drug | campestrol | 2.02e-10 | 49 | 122 | 8 | CID000010134 | |
| Drug | PCB 156 | 2.52e-10 | 31 | 122 | 7 | CID000038019 | |
| Drug | 4'-HPPH | 2.52e-10 | 31 | 122 | 7 | CID000017732 | |
| Disease | X-11793--oxidized bilirubin measurement | 1.09e-16 | 8 | 118 | 7 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.09e-16 | 8 | 118 | 7 | EFO_0022118 | |
| Disease | X-11530 measurement | 1.09e-16 | 8 | 118 | 7 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.09e-16 | 8 | 118 | 7 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 1.09e-16 | 8 | 118 | 7 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 1.09e-16 | 8 | 118 | 7 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.09e-16 | 8 | 118 | 7 | EFO_0800692 | |
| Disease | X-24849 measurement | 1.09e-16 | 8 | 118 | 7 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.09e-16 | 8 | 118 | 7 | EFO_0802740 | |
| Disease | X-16946 measurement | 1.09e-16 | 8 | 118 | 7 | EFO_0800766 | |
| Disease | X-11442 measurement | 4.88e-16 | 9 | 118 | 7 | EFO_0021236 | |
| Disease | X-11441 measurement | 4.88e-16 | 9 | 118 | 7 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 4.88e-16 | 9 | 118 | 7 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 4.88e-16 | 9 | 118 | 7 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 4.88e-16 | 9 | 118 | 7 | EFO_0801036 | |
| Disease | X-11880 measurement | 4.88e-16 | 9 | 118 | 7 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 4.88e-16 | 9 | 118 | 7 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 4.88e-16 | 9 | 118 | 7 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 4.88e-16 | 9 | 118 | 7 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 1.62e-15 | 10 | 118 | 7 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 1.62e-15 | 10 | 118 | 7 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 1.62e-15 | 10 | 118 | 7 | EFO_0802185 | |
| Disease | X-23974 measurement | 1.62e-15 | 10 | 118 | 7 | EFO_0800867 | |
| Disease | plasma N-desmethylclozapine measurement | 4.45e-15 | 11 | 118 | 7 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 4.45e-15 | 11 | 118 | 7 | EFO_0800972 | |
| Disease | X-21796 measurement | 4.45e-15 | 11 | 118 | 7 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 4.45e-15 | 11 | 118 | 7 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 4.45e-15 | 11 | 118 | 7 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 1.06e-14 | 12 | 118 | 7 | EFO_0800079 | |
| Disease | biliverdin measurement | 1.06e-14 | 12 | 118 | 7 | EFO_0021033 | |
| Disease | retinol dehydrogenase 16 measurement | 2.30e-14 | 13 | 118 | 7 | EFO_0802007 | |
| Disease | serum N-desmethylclozapine measurement | 1.00e-13 | 8 | 118 | 6 | EFO_0600043 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 2.57e-13 | 17 | 118 | 7 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 4.19e-13 | 18 | 118 | 7 | EFO_0801382 | |
| Disease | tissue factor measurement | 1.52e-12 | 21 | 118 | 7 | EFO_0010623 | |
| Disease | pregnenetriol sulfate measurement | 1.63e-12 | 11 | 118 | 6 | EFO_0800586 | |
| Disease | pregnenetriol disulfate measurement | 6.03e-12 | 13 | 118 | 6 | EFO_0800587 | |
| Disease | xanthurenate measurement | 1.98e-11 | 29 | 118 | 7 | EFO_0010551 | |
| Disease | response to dolutegravir | 2.58e-11 | 30 | 118 | 7 | EFO_0600017 | |
| Disease | X-21441 measurement | 4.29e-11 | 17 | 118 | 6 | EFO_0800814 | |
| Disease | plasma clozapine measurement | 5.21e-11 | 8 | 118 | 5 | EFO_0600038 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 1.21e-09 | 5 | 118 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 1.21e-09 | 5 | 118 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 1.21e-09 | 5 | 118 | 4 | EFO_0801853 | |
| Disease | thyroxine measurement | 1.58e-09 | 83 | 118 | 8 | EFO_0005130 | |
| Disease | cholelithiasis | 2.53e-09 | 88 | 118 | 8 | EFO_0004799 | |
| Disease | urate measurement, spine bone mineral density | 3.47e-09 | 58 | 118 | 7 | EFO_0004531, EFO_0007701 | |
| Disease | vitamin D deficiency | 7.56e-09 | 37 | 118 | 6 | EFO_0003762 | |
| Disease | X-21339 measurement | 8.43e-09 | 7 | 118 | 4 | EFO_0800808 | |
| Disease | gallstones | 1.30e-08 | 108 | 118 | 8 | EFO_0004210 | |
| Disease | vitamin D measurement, COVID-19 | 4.37e-08 | 49 | 118 | 6 | EFO_0004631, MONDO_0100096 | |
| Disease | hormone measurement | 4.80e-08 | 84 | 118 | 7 | EFO_0004730 | |
| Disease | indole-3-carboxylate measurement | 6.23e-08 | 3 | 118 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 6.23e-08 | 3 | 118 | 3 | EFO_0022216 | |
| Disease | metabolite measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 SLC34A1 SYNE2 UGT2B10 FUT3 DHTKD1 OCSTAMP | 4.08e-07 | 560 | 118 | 13 | EFO_0004725 |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 1.24e-06 | 6 | 118 | 3 | EFO_0800566 | |
| Disease | bilirubin measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 IRX1 RHAG UGT1A4 UGT1A3 UGT2B10 STEAP1B | 1.71e-06 | 442 | 118 | 11 | EFO_0004570 |
| Disease | testosterone measurement | PCSK1 NRDC UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 IRX1 UGT1A4 HMCN1 SLC34A1 SYNE2 MYPN SMARCA2 UGT2B10 LRP5 IL2RG NUP160 | 3.19e-06 | 1275 | 118 | 18 | EFO_0004908 |
| Disease | neuroblastoma, cutaneous melanoma | 4.62e-06 | 28 | 118 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | non-high density lipoprotein cholesterol measurement | USP34 NRDC UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 SLC34A1 SYNE2 SMARCA4 FUT3 | 5.83e-06 | 713 | 118 | 13 | EFO_0005689 |
| Disease | indoleacetate measurement | 7.33e-06 | 10 | 118 | 3 | EFO_0021015 | |
| Disease | X-24588 measurement | 1.73e-05 | 13 | 118 | 3 | EFO_0800898 | |
| Disease | free androgen index | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 SMARCA2 LRP5 NUP160 | 2.04e-05 | 374 | 118 | 9 | EFO_0007005 |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 2.87e-05 | 147 | 118 | 6 | DOID:9352 (biomarker_via_orthology) | |
| Disease | cD177 antigen measurement | 4.87e-05 | 18 | 118 | 3 | EFO_0021866 | |
| Disease | vitamin D measurement | 6.42e-05 | 336 | 118 | 8 | EFO_0004631 | |
| Disease | tapasin-related protein measurement | 9.46e-05 | 4 | 118 | 2 | EFO_0802119 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.57e-04 | 5 | 118 | 2 | C3281201 | |
| Disease | cotinine measurement, trans-3-hydroxycotinine measurement | 2.35e-04 | 6 | 118 | 2 | EFO_0007813, EFO_0010707 | |
| Disease | Loeys-Dietz Syndrome | 3.29e-04 | 7 | 118 | 2 | C2697932 | |
| Disease | palmitoyl dihydrosphingomyelin (d18:0/16:0) measurement | 3.29e-04 | 7 | 118 | 2 | EFO_0800400 | |
| Disease | apolipoprotein B measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 SYNE2 SMARCA4 PLEC | 3.39e-04 | 663 | 118 | 10 | EFO_0004615 |
| Disease | sex interaction measurement, Crohn's disease | 4.39e-04 | 37 | 118 | 3 | EFO_0000384, EFO_0008343 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 5.60e-04 | 9 | 118 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Paranoia | 8.52e-04 | 11 | 118 | 2 | C1456784 | |
| Disease | eosinophil measurement | 9.45e-04 | 108 | 118 | 4 | EFO_0803540 | |
| Disease | dodecanedioate measurement | 1.02e-03 | 12 | 118 | 2 | EFO_0021054 | |
| Disease | Coffin-Siris syndrome | 1.20e-03 | 13 | 118 | 2 | C0265338 | |
| Disease | Astigmatism | 1.82e-03 | 129 | 118 | 4 | HP_0000483 | |
| Disease | thyroid volume | 1.83e-03 | 16 | 118 | 2 | EFO_0004865 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 2.07e-03 | 17 | 118 | 2 | OBA_2045173 | |
| Disease | Omenn Syndrome | 2.59e-03 | 19 | 118 | 2 | C2700553 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 2.71e-03 | 144 | 118 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | Severe Combined Immunodeficiency | 2.87e-03 | 20 | 118 | 2 | C0085110 | |
| Disease | Schizophrenia | COL3A1 RAPGEF6 HLA-A ABCA13 UGT1A3 NDST3 ERVK-8 SMARCA2 DGCR8 IL2RG | 2.92e-03 | 883 | 118 | 10 | C0036341 |
| Disease | coronary atherosclerosis measurement, traffic air pollution measurement | 3.17e-03 | 21 | 118 | 2 | EFO_0007908, EFO_0007938 | |
| Disease | C-peptide measurement | 3.48e-03 | 22 | 118 | 2 | EFO_0005187 | |
| Disease | urate measurement, bone density | 3.49e-03 | 619 | 118 | 8 | EFO_0003923, EFO_0004531 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ILVKWLPQNDLLGHP | 351 | P35503 | |
| HASGWNKILVPLVLL | 146 | Q9BXK5 | |
| WLNKVNPHKPPILIQ | 471 | P51826 | |
| TPSDHPLLPLIWQKF | 1301 | Q9HCE0 | |
| WLKQLQIKLHNPPTI | 86 | Q8N5Z0 | |
| APPMNGLLQLLLHWL | 406 | Q5VXM1 | |
| PNGALVWTFLKPILH | 3301 | Q86UQ4 | |
| VPHSLWPQIKGRLLE | 356 | P30038 | |
| TLVKIWLLVPSHQPA | 51 | Q8N0U6 | |
| FPKLQLEWNVHLNIP | 786 | Q8IYM0 | |
| LQLLHPHVKNWGSLL | 681 | Q8WYQ5 | |
| KWLLQSGIVILLPHG | 686 | Q96HY7 | |
| PLCWLFLKILQPGHS | 16 | Q8N4T0 | |
| WPGHLLDKLQLYLPT | 506 | Q6NXP0 | |
| HLLPNGSLWLSQPLA | 86 | Q8TDY8 | |
| SKLLHKLGQPLPSWL | 851 | O95803 | |
| KLHLPVGLWINSPRK | 16 | Q5U651 | |
| PCAHPWLKLQLALLA | 71 | Q8NBR0 | |
| LWKDIIHNPQALSPQ | 271 | Q68E01 | |
| WKILPQSHLIDLPGS | 321 | Q8NAB2 | |
| LQNLWFLLDKHQTPP | 96 | Q969Q6 | |
| VKGLQLPTPVWFHVL | 186 | Q92637 | |
| AAPWVIAILNPLLHT | 146 | Q8NHA8 | |
| QIHGLPKPLITWEKN | 161 | Q8IVU1 | |
| IHVSWLKDGLPLPLS | 3351 | Q8NDA2 | |
| QPLGLTILGKHLYWI | 1156 | O75197 | |
| AGKPHLVLGLLWQII | 221 | P13797 | |
| PWLLNKELGCINSPL | 386 | Q9UIW2 | |
| VQIEGLINHPPWNLK | 2096 | Q96JB1 | |
| WAVHNGTRPPLIKNL | 241 | O43318 | |
| LHLPDNTLRWKVLPG | 506 | Q6UWB1 | |
| VNQWPLPKQKLEALH | 36 | P63132 | |
| LPGPAHWKSLNLREL | 1211 | Q5S007 | |
| ISPPLNLNPVWFKQH | 151 | Q6YN16 | |
| PVPLGVKQKLLHWVS | 656 | P59047 | |
| KWSLALGLPLPLGEH | 456 | Q96F86 | |
| QLLDLAQKHLGGIPW | 241 | P31930 | |
| VNQWPLPKQKLEALH | 36 | P63135 | |
| VNQWPLPKQKLEALH | 36 | Q9BXR3 | |
| QTLLLSNQLHWPKIP | 1461 | Q96JM4 | |
| VKPQLLLLALVLHPW | 6 | O00469 | |
| WLKNGLPLPLSSHIR | 3376 | Q96RW7 | |
| PKPSINWRKNGHLLN | 3831 | Q96RW7 | |
| LQSRSPGHLPKWLQT | 561 | Q06495 | |
| VNQWPLPKQKLEALH | 36 | Q9QC07 | |
| NPKALSKQPLWNHLL | 886 | Q92900 | |
| IPKGTLILPNLWSVH | 436 | Q7Z449 | |
| KNGVPLLWIKEPHLN | 1161 | O75054 | |
| LLIPKPLNPALWFSH | 11 | P62952 | |
| VPLWKRGPNVLHQNK | 931 | Q9P2H0 | |
| LIKNGQQWPLLIDPH | 2516 | Q0VDD8 | |
| QHEGLPKPLTLRWEL | 286 | P04439 | |
| IPNWLGPLQNLLHIR | 46 | Q8WWB7 | |
| LVIPWAPENLTLHKL | 151 | P31785 | |
| LPPNLHLQILSIPGW | 871 | Q9Y2E5 | |
| WLLNVLFPPHTTPKA | 26 | P04180 | |
| QKGSWLLLALLHPTI | 6 | P02461 | |
| WPLQVSALEIPNKHL | 451 | P48723 | |
| KEGWNPHLLLLLLLV | 231 | Q9HBE5 | |
| GELWALALHPKKPLA | 326 | Q6ZMW3 | |
| IETPLLPHQKQALAW | 236 | Q14527 | |
| SHPWPLAQKIANTLA | 266 | Q6UWW8 | |
| KKWPISGVLPHSGQL | 766 | O95479 | |
| INPAIWIHTPAKVQL | 46 | P0C6P0 | |
| LLAPATAQPLLLWKH | 256 | Q6NUT3 | |
| PPIAGKILWARQLFH | 621 | Q8TE73 | |
| HQVCLQGLWKETLPP | 211 | Q9Y6K5 | |
| HPPLNLSAKTELVAW | 181 | P21217 | |
| WLPPLLNQIALNHKT | 241 | Q49A17 | |
| IIDPNLKHNVLSPGW | 66 | P59025 | |
| NNPALEKLLPHIWGN | 71 | Q8NHW5 | |
| QHGPGWTLLKPSLIK | 1321 | Q8TEU7 | |
| KNEALWHPTLNLPLS | 166 | Q9BX59 | |
| GTPLQNKLPELWALL | 881 | P51531 | |
| LALSSAQPGQLLHWP | 2286 | A2VEC9 | |
| LWAKNLLGELNPSIP | 2741 | Q8WXH0 | |
| GPVPILHIKSQLWLL | 321 | Q6NT16 | |
| QHQLGVWPLLPGSFK | 1856 | P12259 | |
| LWNSIHGLQSPKSPL | 331 | Q14596 | |
| QWGLRHPQILHPKKA | 1296 | Q5VVP1 | |
| APPCTQHITWKGLLL | 6 | Q00889 | |
| LQGAPHGKPKIWSLA | 306 | P78414 | |
| GTPLQNKLPELWALL | 911 | P51532 | |
| LNKGPSLHWILLATL | 1061 | Q5VXU9 | |
| SPHNHPKLQQLWLKA | 76 | Q15475 | |
| TTPNHHIWKQLNLLP | 2386 | Q9UKZ4 | |
| HIWKQLNLLPKPFNL | 2391 | Q9UKZ4 | |
| QATHLLAPPPTWLLQ | 271 | Q9BR26 | |
| LPPGLKQVLHNKLGW | 301 | Q6PJ21 | |
| APPCTQHITWKGLLL | 6 | Q13046 | |
| EQWGLRHPQLLLPKK | 1151 | P0DKV0 | |
| SFLLHLWDPNPKIGV | 1436 | Q7Z745 | |
| LAPLPGLLQKVLIWS | 71 | Q5SWA1 | |
| INKLLSHGVPLPNWL | 1311 | Q12769 | |
| AWQGHLPIVKLLAKQ | 626 | P57078 | |
| ELFPQWHLPIKIAAI | 66 | Q9UHE8 | |
| QELFPQWHLPIKIAA | 46 | Q6NZ63 | |
| QLGHLALKPKQPWHL | 236 | Q8N365 | |
| LDLLSHSAKVQPQPW | 106 | Q96DZ9 | |
| VNQWPLPKQKLEALH | 36 | P63136 | |
| LVLRNLKSPIPLWGH | 231 | Q9BXU1 | |
| LWTGLPGPNLHLLVA | 516 | Q9HA65 | |
| TILVKWLPQNDLLGH | 346 | Q9HAW8 | |
| GQALKWQQHQGLLPP | 166 | Q2TAY7 | |
| HLNGPLQWLDKVLTQ | 441 | Q15796 | |
| VLKPHALGKPWASQQ | 571 | Q96PX9 | |
| GQPIHLWQFLKELLL | 246 | O95238 | |
| LPLLKGLLFHPEWVV | 396 | O14787 | |
| VNQWPLPKQKLEALH | 36 | P10266 | |
| GENQLPVWLPTRHLK | 841 | P10266 | |
| VNQWPLPKQKLEALH | 36 | P63133 | |
| ILVKWLPQNDLLGHP | 351 | P35504 | |
| KIHALTITWALPPQQ | 436 | O43847 | |
| VNQWPLPKQKLEALH | 36 | Q9UQG0 | |
| LILKLPLWGQPSDQN | 381 | Q02094 | |
| QKQPSLLPEGLWLLN | 351 | Q96DC7 | |
| VLFGSHQALVQWKPP | 566 | P08922 | |
| HQALVQWKPPALAIG | 571 | P08922 | |
| QLVGPAQPSHWKVLS | 966 | Q15149 | |
| TILVKWLPQNDLLGH | 346 | O60656 | |
| QTQPLWHQLGLVLAK | 86 | Q8N7F7 | |
| RLYKWIPQNDLLGHP | 351 | P36537 | |
| VQLHWEGQLLPPKLL | 586 | Q8TEQ8 | |
| LALQHSWKQGEPLIA | 536 | Q8NEE8 | |
| VNQWPLPKQKLEALH | 36 | Q9WJR5 | |
| LPLGSLVLVKLQNWP | 96 | Q504Y3 | |
| EGLPLHLALFPKLWT | 3176 | Q70CQ2 | |
| PQILLGGNLSWHPAL | 181 | Q8TB96 | |
| APPCTQHITWKGLLL | 6 | Q15238 | |
| IWQLVPPSLFKGSHI | 156 | Q96RL1 | |
| TILVKWLPQNDLLGH | 346 | Q9HAW7 | |
| TILVKWLPQNDLLGH | 346 | Q9HAW9 | |
| PSPLTLHTVQKWLLA | 91 | O14773 | |
| ILVKWLPQNDLLGHP | 351 | P22310 | |
| HTWQAQAVPILPLGL | 16 | Q96L15 | |
| WLLNGQPVLPDASHK | 1106 | Q86TC9 | |
| LPKLDLHVIPVWQKG | 141 | P29120 |